Farnum Rhonda's Form 4 filing
Theravance Biopharma, Inc. (TBPH) · filed Jun 4, 2025
- Accession no.
- 0001415889-25-015642
- Filed
- Jun 4, 2025
- Trade date
- Jun 2, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $264.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Farnum RhondaCIK 0001898490 | Officer (SVP, COMM & MEDICAL AFFAIRS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2025 | Ordinary Shares | SSaleDisposed | −24,000 | $11.00 | −$264,000 | 336,918 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.